thymoma |
Disease ID | 223 |
---|---|
Disease | thymoma |
Manually Symptom | UMLS | Name(Total Manually Symptoms:86) C2707258 | infections C2700513 | aplastic anemia C2242624 | pure white cell aplasia C1963198 | pancreatitis C1963091 | diarrhea C1868690 | addison disease C1608408 | malignant transformation C1415107 | stiff person syndrome C1368107 | bone marrow aplasia C1290344 | nonspecific interstitial pneumonia C1112570 | paraneoplastic pemphigus C1000483 | anemia C0877221 | erythroblastopenia C0876973 | pulmonary infections C0865240 | red cell aplasia C0836924 | thrombocytosis C0702094 | agranulocytosis C0585186 | cutaneous hypersensitivity C0521173 | granulomatosis C0497327 | dementia C0494165 | liver metastasis C0494165 | hepatic metastasis C0442874 | neuropathy C0398581 | t-cell lymphocytosis C0343192 | microscopic polyangiitis C0340161 | mediastinal hematoma C0338430 | limbic encephalitis C0334415 | chromaffinoma C0279706 | thymic lymphoepithelioma-like carcinoma C0276253 | cytomegalovirus pneumonia C0271844 | parathyroid hyperplasia C0263313 | pemphigus foliaceus C0263312 | pemphigus erythematosus C0242287 | continuous muscle fiber activity C0238097 | cytomegalovirus encephalitis C0234131 | motor dysfunction C0153678 | pleural metastases C0153676 | pulmonary metastases C0153676 | lung metastasis C0152902 | esophageal tuberculosis C0151773 | marrow hypoplasia C0086438 | hypogammaglobulinemia C0086438 | hypogammaglobulinaemia C0085655 | polymyositis C0085292 | stiff-person syndrome C0038454 | stroke C0037274 | skin diseases C0037274 | dermatologic disorders C0034902 | pure red cell aplasia C0033975 | psychosis C0032305 | pneumocystis carinii pneumonia C0031511 | phaeochromocytoma C0030805 | pemphigoid C0030472 | paraneoplastic syndromes C0030472 | paraneoplastic syndrome C0030312 | pancytopenia C0030196 | limb pain C0027726 | nephrotic syndrome C0027126 | myotonic dystrophy C0027126 | dystrophia myotonica C0027121 | myositis C0026896 | myasthenia gravis C0024282 | lymphocytosis C0023968 | loa loa infection C0023646 | lichen planus C0022658 | renal disease C0022658 | nephropathies C0021847 | intestinal pseudo-obstruction C0021051 | immunodeficiency C0019348 | herpes simplex C0018939 | hematologic disorders C0018023 | nodular goiter C0014038 | encephalitis C0009450 | infectious diseases C0009447 | common variable hypogammaglobulinaemia C0009447 | acquired hypogammaglobulinaemia C0009447 | acquired agammaglobulinemia C0008311 | cholangitis C0005747 | blepharospasm C0004364 | autoimmune diseases C0004364 | autoimmune disease C0002881 | hereditary hemolytic anemia C0002880 | autoimmune haemolytic anaemia C0002878 | hemolytic anemia C0002874 | aplastic anaemia C0001824 | granulocytopenia |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:25) C0026896 | myasthenia gravis | 56 C0021051 | immunodeficiency | 10 C0034902 | pure red cell aplasia | 8 C0281963 | red cell aplasia | 8 C0004364 | autoimmune disease | 5 C0014038 | encephalitis | 5 C0338430 | limbic encephalitis | 4 C0086438 | hypogammaglobulinemia | 4 C0030472 | paraneoplastic syndrome | 3 C0021311 | infections | 2 C0030472 | paraneoplastic syndromes | 2 C0085292 | stiff-person syndrome | 2 C0024282 | lymphocytosis | 2 C0398581 | t-cell lymphocytosis | 2 C0027126 | myotonic dystrophy | 1 C0086438 | hypogammaglobulinaemia | 1 C0002878 | hemolytic anemia | 1 C0263313 | pemphigus foliaceus | 1 C0004364 | autoimmune diseases | 1 C0027121 | myositis | 1 C0030312 | pancytopenia | 1 C0027726 | nephrotic syndrome | 1 C0023646 | lichen planus | 1 C0002871 | anemia | 1 C0002874 | aplastic anemia | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:19) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs104894226 | 19861435 | 3265 | HRAS | umls:C0040100 | BeFree | One thymoma and one thymic carcinoma harbored KRAS mutations (G12A and G12V, respectively), and one thymoma had a G13V HRAS mutation. | 0.000814326 | 2009 | HRAS;LRRC56 | 11 | 534285 | C | T,A |
rs104894226 | 19861435 | 3845 | KRAS | umls:C0040100 | BeFree | One thymoma and one thymic carcinoma harbored KRAS mutations (G12A and G12V, respectively), and one thymoma had a G13V HRAS mutation. | 0.000814326 | 2009 | HRAS;LRRC56 | 11 | 534285 | C | T,A |
rs104894230 | 19861435 | 3265 | HRAS | umls:C0040100 | BeFree | One thymoma and one thymic carcinoma harbored KRAS mutations (G12A and G12V, respectively), and one thymoma had a G13V HRAS mutation. | 0.000814326 | 2009 | HRAS;LRRC56 | 11 | 534288 | C | T,G,A |
rs104894230 | 19861435 | 3845 | KRAS | umls:C0040100 | BeFree | One thymoma and one thymic carcinoma harbored KRAS mutations (G12A and G12V, respectively), and one thymoma had a G13V HRAS mutation. | 0.000814326 | 2009 | HRAS;LRRC56 | 11 | 534288 | C | T,G,A |
rs112445441 | 19861435 | 3845 | KRAS | umls:C0040100 | BeFree | One thymoma and one thymic carcinoma harbored KRAS mutations (G12A and G12V, respectively), and one thymoma had a G13V HRAS mutation. | 0.000814326 | 2009 | KRAS | 12 | 25245347 | C | A,G,T |
rs112445441 | 19861435 | 3265 | HRAS | umls:C0040100 | BeFree | One thymoma and one thymic carcinoma harbored KRAS mutations (G12A and G12V, respectively), and one thymoma had a G13V HRAS mutation. | 0.000814326 | 2009 | KRAS | 12 | 25245347 | C | A,G,T |
rs121434569 | 24698130 | 5291 | PIK3CB | umls:C0040100 | BeFree | The PC-9-derived NSCLC cell lines PC-9ER and PC-9ZD, resistant to EGFR-TKI due to v-crk avian sarcoma virus CT10 oncogene homolog-like (CRKL) amplification-induced phosphatidylinositol 3-kinase (PI3K)/v-akt murine thymoma viral oncogene homolog (AKT) activation and an EGFR T790M mutation, respectively, were used. | 0.002171535 | 2014 | EGFR;EGFR-AS1 | 7 | 55181378 | C | T |
rs121434569 | 24698130 | 5294 | PIK3CG | umls:C0040100 | BeFree | The PC-9-derived NSCLC cell lines PC-9ER and PC-9ZD, resistant to EGFR-TKI due to v-crk avian sarcoma virus CT10 oncogene homolog-like (CRKL) amplification-induced phosphatidylinositol 3-kinase (PI3K)/v-akt murine thymoma viral oncogene homolog (AKT) activation and an EGFR T790M mutation, respectively, were used. | 0.002171535 | 2014 | EGFR;EGFR-AS1 | 7 | 55181378 | C | T |
rs121434569 | 24698130 | 5290 | PIK3CA | umls:C0040100 | BeFree | The PC-9-derived NSCLC cell lines PC-9ER and PC-9ZD, resistant to EGFR-TKI due to v-crk avian sarcoma virus CT10 oncogene homolog-like (CRKL) amplification-induced phosphatidylinositol 3-kinase (PI3K)/v-akt murine thymoma viral oncogene homolog (AKT) activation and an EGFR T790M mutation, respectively, were used. | 0.002442977 | 2014 | EGFR;EGFR-AS1 | 7 | 55181378 | C | T |
rs121434569 | 24698130 | 5293 | PIK3CD | umls:C0040100 | BeFree | The PC-9-derived NSCLC cell lines PC-9ER and PC-9ZD, resistant to EGFR-TKI due to v-crk avian sarcoma virus CT10 oncogene homolog-like (CRKL) amplification-induced phosphatidylinositol 3-kinase (PI3K)/v-akt murine thymoma viral oncogene homolog (AKT) activation and an EGFR T790M mutation, respectively, were used. | 0.002171535 | 2014 | EGFR;EGFR-AS1 | 7 | 55181378 | C | T |
rs121434569 | 24698130 | 1956 | EGFR | umls:C0040100 | BeFree | The PC-9-derived NSCLC cell lines PC-9ER and PC-9ZD, resistant to EGFR-TKI due to v-crk avian sarcoma virus CT10 oncogene homolog-like (CRKL) amplification-induced phosphatidylinositol 3-kinase (PI3K)/v-akt murine thymoma viral oncogene homolog (AKT) activation and an EGFR T790M mutation, respectively, were used. | 0.006253095 | 2014 | EGFR;EGFR-AS1 | 7 | 55181378 | C | T |
rs121434569 | 24698130 | 1399 | CRKL | umls:C0040100 | BeFree | The PC-9-derived NSCLC cell lines PC-9ER and PC-9ZD, resistant to EGFR-TKI due to v-crk avian sarcoma virus CT10 oncogene homolog-like (CRKL) amplification-induced phosphatidylinositol 3-kinase (PI3K)/v-akt murine thymoma viral oncogene homolog (AKT) activation and an EGFR T790M mutation, respectively, were used. | 0.000271442 | 2014 | EGFR;EGFR-AS1 | 7 | 55181378 | C | T |
rs121913529 | 19861435 | 3265 | HRAS | umls:C0040100 | BeFree | One thymoma and one thymic carcinoma harbored KRAS mutations (G12A and G12V, respectively), and one thymoma had a G13V HRAS mutation. | 0.000814326 | 2009 | KRAS | 12 | 25245350 | C | T,G,A |
rs121913529 | 19861435 | 3845 | KRAS | umls:C0040100 | BeFree | One thymoma and one thymic carcinoma harbored KRAS mutations (G12A and G12V, respectively), and one thymoma had a G13V HRAS mutation. | 0.000814326 | 2009 | KRAS | 12 | 25245350 | C | T,G,A |
rs1863800 | 25003519 | 1493 | CTLA4 | umls:C0040100 | BeFree | A predisposing effect of rs1863800*C, rs733618*C, and rs231775*G of CTLA4 gene to general risk of MG in Chinese was demonstrated for the first time, which was likely derived from EOMG, SPMG, MG without thymoma and the female patients. | 0.004624443 | 2014 | NA | 2 | 203837937 | C | T |
rs231775 | 25003519 | 1493 | CTLA4 | umls:C0040100 | BeFree | A predisposing effect of rs1863800*C, rs733618*C, and rs231775*G of CTLA4 gene to general risk of MG in Chinese was demonstrated for the first time, which was likely derived from EOMG, SPMG, MG without thymoma and the female patients. | 0.004624443 | 2014 | CTLA4 | 2 | 203867991 | A | G,T |
rs2476601 | 25119822 | 26191 | PTPN22 | umls:C0040100 | BeFree | DNA samples from 416 patients with clinically diagnosed generalized MG (231 with Abs to acetylcholine receptor, AChR-MG), 53 with Abs to muscle-specific kinase (MuSK-MG), 55 patients with no detectable Abs (SN-MG), 77 patients with thymoma (TAMG) and 293 healthy controls (HC) were genotyped for the SNP (PTPN22 R620W, C1858T, rs2476601). | 0.005905708 | 2014 | PTPN22;AP4B1-AS1 | 1 | 113834946 | A | G |
rs2476601 | 25119822 | 27335 | EIF3K | umls:C0040100 | BeFree | DNA samples from 416 patients with clinically diagnosed generalized MG (231 with Abs to acetylcholine receptor, AChR-MG), 53 with Abs to muscle-specific kinase (MuSK-MG), 55 patients with no detectable Abs (SN-MG), 77 patients with thymoma (TAMG) and 293 healthy controls (HC) were genotyped for the SNP (PTPN22 R620W, C1858T, rs2476601). | 0.000271442 | 2014 | PTPN22;AP4B1-AS1 | 1 | 113834946 | A | G |
rs733618 | 25003519 | 1493 | CTLA4 | umls:C0040100 | BeFree | A predisposing effect of rs1863800*C, rs733618*C, and rs231775*G of CTLA4 gene to general risk of MG in Chinese was demonstrated for the first time, which was likely derived from EOMG, SPMG, MG without thymoma and the female patients. | 0.004624443 | 2014 | CTLA4 | 2 | 203866221 | T | C |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:1) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0040100 | octreotide | D015282 | 83150-76-9 | thymoma | MESH:D013945 | therapeutic | 10509161 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |